Good morning, everyone, and welcome to Insulet's 2025 Investor Day. I'm Clare Trachtman, Vice President of Investor Relations. And on behalf of the entire team, I'd like to thank you all for joining ...

Second-year receiver Adonai Mitchell, who arrived to the Jets via the Sauce Gardner deadline deal with the Colts last month, ...

Torrey Pines High School. I’ve been living with Type 1 diabetes for over five years, and this weekend, I’ll be attending the ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Growth stocks are still on the menu for 2026. The first few months of 2025 were a roller-coaster ride that threatened to ...

The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet ...

The FDA cleared an updated algorithm for a hybrid closed-loop insulin delivery system that permits users to set a lower ...

Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their ...

Insulet Corporation delivers strong fundamentals, with robust revenue growth, high margins, and impressive ROC. Learn more ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received FDA 510(k) ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Since 3D printers debuted in the 1980s, the devices have been used ...